These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20583292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 4. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA, Hilton J, Jepson B, Smith L.
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [Abstract] [Full Text] [Related]

  • 5. [Current therapeutic agents: dornase alfa].
    Baran D, Sternon J.
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.
    Hodson ME, McKenzie S, Harms HK, Koch C, Mastella G, Navarro J, Strandvik B, Investigators of the Epidemiologic Registry of Cystic Fibrosis.
    Pediatr Pulmonol; 2003 Nov; 36(5):427-32. PubMed ID: 14520726
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dornase alfa in early cystic fibrosis lung disease.
    Robinson PJ.
    Pediatr Pulmonol; 2002 Sep; 34(3):237-41. PubMed ID: 12203856
    [Abstract] [Full Text] [Related]

  • 12. Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.
    MacConnachie AM.
    Intensive Crit Care Nurs; 1998 Apr; 14(2):101-2. PubMed ID: 9814214
    [Abstract] [Full Text] [Related]

  • 13. Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ.
    J Pediatr; 1999 Jun; 134(6):734-9. PubMed ID: 10356143
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
    Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.
    Respiration; 2001 Jun; 68(2):160-4. PubMed ID: 11287830
    [Abstract] [Full Text] [Related]

  • 19. The role of dornase alfa in the treatment of cystic fibrosis.
    Cramer GW, Bosso JA.
    Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.